Mindfulness Based Stress Reduction in the management of psychological distress in prostate cancer

Understanding depression and anxiety in prostate cancer: a feasibility study and qualitative evaluation of Mindfulness Based Stress Reduction (MBSR) for the management of depression and anxiety in men with prostate cancer undergoing active surveillance

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN80592494

Enrollment

Registered

2011-10-31

Start date

2012-01-09

Completion date

Unknown

Last updated

2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer patients undergoing active surveillance Cancer Malignant neoplasm of prostate

Interventions

MBSR is a psycho-educational treatment for the management of depression and anxiety Follow Up Length: 4 months

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. HADS>8 2. English fluency (questionnaires only validated in English) 3. Diagnosed > 2 months to avoid the period of initial 'shock of diagnosis' 4. No other current serious life threatening co-morbidity an ECOG score of 0 or 1 (i.e. patients are fully active or with restricted mobility but are ambulatory and be able to carry out work of a light or sedentary nature 5. Male participants

Exclusion criteria

Exclusion criteria: Secondary cancer sites

Design outcomes

Primary

Measure	Time frame
Depression and anxiety scores measured at baseline and monthly for 4 months	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026